Mitsui Chemicals, Inc.

Mitsui Chemicals, Inc.

4183.T
Mitsui Chemicals, Inc.JP flagTokyo Stock Exchange
2,128.00
JPY
-29.50
- -
783.32BMarket Cap
Mitsui Chemicals, Inc.
4183.T
(Tokyo Stock Exchange)

Recent

price

2,128.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
3,471.84
3,628.33
3,509.55
3,909.46
3,871.01
3,357.41
3,029.33
3,325.52
3,756.22
3,466.56
3,119.75
4,145.37
4,885.75
4,601.74
4,785.23
4,447.5
2,435.37
Revenue per Share
62
-2.51
-20.34
-62.75
43.11
57.37
162.02
179.19
192.8
87.26
149
282.73
215.59
131.49
85.28
91.62
77.08
Basic EPS, GAAP
76.5
15.45
-83.79
-25
51.97
261.14
147.29
75.06
136.12
109.07
251.65
-60.75
-95.19
19.32
164.24
- -
-41.05
Free Cash Flow per Basic Share
15
15
15
15
5
17.5
22.5
45.07
47.82
50.11
49.82
52.76
62.8
65
72.93
- -
35
Dividend per Share
815.11
1,025.01
989.73
912.19
952.79
991.88
1,130.75
1,265.23
1,205.46
1,246.07
1,414.54
1,648.99
1,821.41
1,954.42
1,968
2,005.15
1,972.47
Book Value per Share
1,047.27
1,008.53
1,033.93
842.37
995.27
1,006.96
1,198.07
1,391.12
1,532.95
1,498.78
1,702.75
1,911.92
2,120.69
2,389.04
2,336.27
2,374.14
2,360.68
Tangible Book Value per Share
401
401
401
401
400
400
400
399
395
389
388
389
385
380
378
375
380
Basic Weighted Avg Shares
1,391,713
1,454,024
1,406,220
1,566,046
1,550,076
1,343,898
1,212,282
1,328,526
1,482,909
1,349,522
1,211,725
1,612,688
1,879,547
1,749,743
1,809,164
1,668,754
926,088
Sales/Revenue/Turnover
2.91
1.48
0.31
1.59
2.71
5.28
8.43
7.79
6.3
4.45
5.95
7.53
5.71
3.53
3.64
3.39
3.91
Operating Margin (%)
69,237
62,749
43,864
48,143
48,251
48,640
44,057
45,654
49,504
76,009
76,621
84,222
92,080
95,249
99,768
- -
48,969
Depreciation Expense
24,854
-1,007
-8,149
-25,138
17,261
22,963
64,839
71,585
76,115
33,970
57,873
109,990
82,936
49,999
32,242
34,378
29,311
Net Income, GAAP
24.57
53.73
- -
- -
32.03
28.65
13.89
16.12
17.83
29.93
13.5
16.08
23.14
26.67
40.5
31.63
26.99
Effective Tax Rate (%)
1.79
-0.07
-0.58
-1.61
1.11
1.71
5.35
5.39
5.13
2.52
4.78
6.82
4.41
2.86
1.78
2.06
3.17
Profit Margin (%)
223,678
209,804
221,488
269,959
283,209
263,951
286,155
288,221
304,604
296,160
321,267
326,876
398,842
474,000
435,244
402,058
458,850
Working Capital
324,733
294,501
320,956
389,595
368,996
339,299
304,228
305,963
322,749
313,237
293,495
319,471
369,786
432,670
455,489
443,464
447,771
LT Debt
431,101
415,771
428,914
409,647
471,299
443,237
514,635
587,222
631,063
609,707
682,157
807,122
883,303
984,806
970,604
988,784
978,640
Total Equity
3.97
1.35
- -
- -
3.47
6.2
10.91
10.06
7.47
3.64
5.82
9.61
6.87
3.38
2.75
2.44
1.59
Return on Invested Capital (%)
3.07
-0.87
- -
- -
1.86
2.63
7.51
8.05
7.18
2.91
5.77
11.32
8.02
4.62
2.34
2.25
2.41
Return on Capital (%)
7.83
-0.27
-2.02
-6.6
4.62
5.9
15.26
14.95
15.51
7.07
11.19
18.47
12.36
6.93
4.34
4.59
4
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
324,088
- -
228,721
LT Borrowings
432,670
- -
447,771
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
380
- -
380
Market Capitalization
823,390
844,204
723,456

Working Capital

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
1,150,579
- -
1,012,954
Cash, Cash Equivalents & STI
249,510
- -
207,377
Accounts Receivable, Net
365,896
- -
318,694
Inventories
451,075
- -
453,115
Total Current Liabilities
676,579
- -
554,104
Payables & Accruals
- -
- -
- -
ST Debt
324,088
- -
228,721
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.59%
7.94%
1.87%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
21.09%
-0.63%
6.62%
Sales/Revenue/Turnover
3.06%
7.67%
-7.76%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
407,925
415,730
450,875
475,213
1,749,743
2025
- -
- -
- -
- -
1,809,164
2026
- -
- -
- -
- -
1,668,754

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
25.23
29.18
43.58
- -
131.49
2025
- -
- -
- -
- -
85.28
2026
- -
- -
- -
- -
91.62

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
30
- -
35
- -
65
2025
- -
- -
- -
- -
72.93
2026
- -
- -
- -
- -
- -
Business
Mitsui Chemicals, Inc. (4183.T) manufactures and markets a broad portfolio of advanced chemicals and materials for mobility, health care, food and packaging, basic materials, and other applications. The company produces elastomers, performance compounds, functional polymers, polypropylene compounds, and performance polymers for automotive and industrial uses; vision care materials including ophthalmic lens materials, photochromic lens materials, and coating materials, nonwoven fabrics, dental materials, personal care materials, and raw materials for pharmaceuticals and cosmetics in health care; coating and engineering materials, performance films and sheets, and agrochemical products for food and packaging; ethylene, propylene, polyethylene, polypropylene, catalysts, phenols, purified terephthalic acid, PET, polyurethane materials, and industrial chemicals in basic materials; as well as semiconductor solutions including electronic component processing materials, optical materials, and lithium-ion battery materials, imaging solutions such as lens materials, reflective films, and LCD and OLED sealing materials, and functional food packaging materials. Founded in 1912 and headquartered in Tokyo, Japan, Mitsui Chemicals operates production facilities and sales offices across Japan, China, Asia, the Americas, Europe, and other international markets, with regional headquarters in China, Germany, the United States, and Singapore. In recent developments, the company launched its second corporate venture capital fund, 321Catalyst™, with a $60 million size and a 10-year life, managed by new subsidiary 321Catalyst Ventures, Inc., to invest in startups across life & healthcare, mobility, ICT, sustainability, and other sectors as part of VISION 2030; fully acquired Nippon Aluminum Alkyls, a producer of co-catalysts for polyolefins; signed a memorandum of understanding with Idemitsu Kosan and Sumitomo Chemical to integrate Sumitomo's PP and LLDPE businesses into Prime Polymer to enhance domestic polyolefin competitiveness; entered an MOU with Asahi Kasei and Mitsubishi Chemical for a limited liability partnership on ethylene manufacturing facilities in western Japan; and partnered with Polyplastics on marketing operations for engineering plastic products, while expanding R&D and manufacturing through subsidiaries like SDC Technologies in the United States and Kulzer in EMEA, the Americas, and Saudi Arabia.